Compositions and methods for regulating phagocytosis and ICAM-1 expression

Details for Australian Patent Application No. 2006203246 (hide)

Owner Johnson & Johnson Consumer Companies, Inc.

Inventors Miri, Seiberg; Eisinger, Magdalena; Shapiro, Stanley S

Agent Shelston IP

Pub. Number AU-A-2006203246

Parent 2003204412

Filing date 25 July 2006

Wipo publication date 17 August 2006

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 7/00 (1968.09)

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

17 August 2006 Application Open to Public Inspection

  Published as AU-A-2006203246

17 August 2006 Complete Application Filed

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203247-Brewing apparatus for preparing foam, froth, or crema under low pressure

2006203245-A method for printing a substrate with radiation curable ink, and an ink suitable for application in the said method